Partner Companies

Merck

Merck Website
2000 Galloping Hill Road, Kenilworth, NJ 07033

Fellowship Duration

2 years

Fellowship Positions Available

Clinical Safety and Risk Management

Regulatory Affairs Advertising and Promotion

Late Stage Clinical Development: Oncology

Late Stage Clinical Development: Infectious Diseases & Vaccines

Quantitative Pharmacology and Pharmacometrics

Translational Pharmacology

Global Medical Information (GMI)/Oncology Global Medical Affairs (OGMA)

US Medical Affairs

Global Medical Information

Company Information

At Merck we are committed to improving health and wellbeing around the world.  Merck’s core values are driven by a desire to improve human life, achieve scientific excellence, operate with the highest standards of integrity, expand access to our products and employ a diverse workforce that values collaboration.

Merck Research Laboratories (MRL) and Global Human Health (GHH) have designed a two-year fellowship program that will offer fellows a tremendous opportunity to learn, grow, and be part of a dynamic and exciting culture. We believe the fellowships offer a unique opportunity to build skills and gain hands-on experience that will be invaluable in pursuing a career in the dynamic and fast-changing pharmaceutical industry.

Position Detailed Descriptions

Clinical Safety and Risk Management

As a member of the Clinical Safety & Risk Management (CSRM) department within Global Regulatory Affairs &Clinical Safety, the CSRM fellow will develop expertise in the overall clinical risk management and safety surveillance of assigned marketed products. She or he will learn about all aspects of safety surveillance, including assessing safety information, safety signaling, and ensuring completeness of safety information in worldwide package circulars. Additionally, she or he will have joint responsibility for the development of periodic safety update reports and risk management plans while collaborating with other departments across the Company.

Regulatory Affairs Advertising and Promotion

The two-year regulatory fellowship at Merck will focus in the Office of Promotions and Advertising Review (OPAR) group within GRACS. This group is responsible for ensuring advertising and promotion materials are compliant and accurately reflect the unique characteristics which differentiate our products and our company in the marketplace. The fellow will have the opportunity to develop an understanding of federal regulations and guidance related to advertising and promotion of prescription drugs and biologics, and to collaborate with a variety of functions to ensure promotional activities are compliant with regulations and corporate policies.

Late Stage Clinical Development: Oncology | Late Stage Clinical Development: Infectious Diseases & Vaccines

Clinical Sciences & Study Management (CSSM) is a sub-functional unit within Global Clinical Trial Operations (GCTO) accountable for all operational, technical and scientific aspects of headquarters-sponsored clinical trials, including local registration trials and regulatory commitments. The Clinical Scientist (CS)/Study Manager (SM) fellow(s) will support the scientific aspects of late stage clinical development within therapeutic areas of oncology, infectious disease, or vaccines, as well as play a key role in the operational planning and execution activities for our late stage development clinical studies. Through involvement and interaction with other functional areas and external experts, the fellow will become familiar with, protocol design, scientific and operational oversight of trials, patient recruitment and retention, results reporting, and more. Overall, the fellows will have the chance to help advance Merck’s pipeline of innovative drug candidates so that they might benefit people around the world.

Quantitative Pharmacology and Pharmacometrics

The Quantitative Pharmacology and Pharmacometrics (QP2) group is responsible for developing and executing PK/PD and Modeling & Simulation (M&S) strategies and applying functional area knowledge to frame critical drug development questions for optimizing model-based drug development as a member of cross-functional drug development teams. The QP2 fellow will be responsible for developing expertise in PK/PD and M&S through efforts designed to support various therapeutic areas. This fellowship is particularly suited to those looking for a research-based scientific experience that leverages foundational science and physiological principles to drive decision making, and is less focused on operational aspects of drug development.

Translational Pharmacology

The Early Clinical Scientist (ECS) fellow will be part of Translational Pharmacology Clinical Operations (TPCO) and will support the department of Translational Pharmacology (TPharm). The mission of TPharm is to discover novel targets and biomarkers to initiate new programs, conduct early clinical development trials to test therapeutic hypothesis and to support late development programs through filing approval. The fellow will be responsible for developing protocols, creating case report forms for data collection, initiating studies, data monitoring, data clean-up, and reporting of studies. The focus of the investigations will be geared toward the understanding of new molecular entity (NME) safety and tolerability in healthy subjects and patients, mechanism of action pharmacokinetics, pharmacodynamics, as well as proof of concept.

Global Medical Information (GMI)/Oncology Global Medical Affairs (OGMA)

The Global Medical Affairs (GMA) fellows will have broad experiences across the organization while focusing on Oncology. They will gain experience within 1.) Global Medical Information (learning about: unsolicited Professional Information Requests (PIRS), medical review of promotional materials for marketed Oncology products, development and delivery of training materials, and launch activities around the globe) and 2) Oncology Global Medical Affairs (focusing on Scientific Leader engagements, Oncology Global Medical Affairs Strategy and associated content creation, Oncology Global Medical Affairs Plans and operational projects that directly support the organization.

US Medical Affairs

USMA partners with internal and external stakeholders to communicate relevant information that enables appropriate, accurate and timely access to relevant Merck science and therapies. USMA Fellows will gain broad Medical Affairs experience by rotating through functions in the USMA organization that include those noted below and across a broad range of therapeutic areas including cardiovascular and metabolic, infectious disease, surgery/anesthesia, neuroscience, and virology.

  • Field Medical: Engage in scientific and medical discussions with scientific leaders (Healthcare Providers) and key decision makers
  • Therapeutic and Customer Segment Strategy: Participate in the input gathering and strategic decision process to support the development of appropriate medical affairs strategies
  • Content and Training: Drive the creation, review and approval, and training and implementation of medical and scientific content to enable external engagement with scientific leaders and key decision makers
  • Strategy & Operations: Execute cross-functional projects required to achieve USMA organizational objectives
  • Advocacy and Professional Affairs: Engage with professional organizations and attend conferences that are supported by Merck through the APA processes

Global Medical Information

The Global Medical Affairs (GMA) fellows will have broad experiences across the organization. They will gain experience within Global Medical Information (learning about: unsolicited Professional Information Requests (PIRS), medical review of promotional materials for marketed products, development and delivery of training materials, and launch activities around the globe. They will interact and collaborate with medical/scientific colleagues across the company, and will learn how all these roles work together to support our customers and their patients.

Download Brochure